This country profile provides an overview of Niger’s progress in reaching those in need of mass NTD treatment based on 2017 data.

*This includes all countries in Africa that are endemic for at least one of the five NTDs

Download country profiles

Treatment coverage

Elephantiasis
72%
Blinding trachoma
27%
Intestinal worms
87%
Bilharzia
100%
River blindness
N/A
12.32 million people received treatment in Niger in 2017 1.75 million people did not receive treatment in Niger in 2017

Priorities for progress in Niger

  • Niger is commended for the excellent progress made in 2017 in increasing coverage for LF, SCH and STH.
  • As a priority, it is encouraged to work to systematically increase and maintain high annual coverage levels for all the four preventative chemotherapy NTDs that are endemic in Niger.
  • Support the Expanded Special Project for Elimination of Neglected Tropical Diseases (ESPEN) established by WHO AFRO region for the elimination of these five diseases.

Elephantiasis

Treatment coverage was not reported in 2016 and 72% in 2017.

People needing treatment
9.8m
People receiving treatment
7.02m

Blinding trachoma

Treatment coverage decreased from 52% in 2016 to 27% in 2017.

People needing treatment
7.85m
People receiving treatment
2.15m

Intestinal worms

Treatment coverage was not reported in 2016 and 87% in 2017.

Pre-sch and school-aged children needing treatment
8.74m
Pre-school and school-aged children receiving treatment
7.63m

Bilharzia

Treatment coverage was not reported in 2016 and 100% in 2017.

School-aged children needing treatment
3.44m
School-aged children receiving treatment
3.44m

River blindness

Niger does not require mass treatment for river blindness.

The ESPEN portal (a World Health Organization AFRO region project) provides maps and district-level data for the preventive chemotherapy diseases in Niger.